{
  "catalogId": "09acf7e7-0216-474e-9d6a-9a9512e0e042",
  "name": "PLUVICTO",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "172 79 37413 99",
  "treatmentDescriptions": "Pluvicto is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy or who are not medically suitable for taxanes.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection / infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN 1000 MBQ/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "V10XX05",
      "name": "LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "PLUVICTO SOL FOR INJ / INF 1VIAL",
      "manufacturer": {
        "name": "נוברטיס פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "5",
      "storageConditions": "",
      "codes": {
        "moh": "9237",
        "yarpa": "17429",
        "barcode": "7290019217695"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 80950.76333,
        "retailMargin": 10.0,
        "maxRetailPrice": 89045.83967,
        "maxPriceWithVAT": 105074.0861
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:42.950377"
  }
}